Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04586335 |
| Title | Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | ShangHai HaiHe Pharmaceutical |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale Cancer Center | New Haven | Connecticut | 06519 | United States | Details | |
| UT Southwestern: Simmons Cancer Center | Dallas | Texas | 75390 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Scientia Cancer Centre | Sydney | New South Wales | 2031 | Australia | Details | |
| Integrated Oncology Network PTY LTD | Brisbane | Queensland | 4101 | Australia | Details | |
| Monash Cancer Centre | Melbourne | Victoria | 3168 | Australia | Details | |
| Fudan University - Pudong Medical Center | Shanghai | Shanghai | China | Details |